1. Heald R, Ryall R. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;327:1479-82.
2. Bosch SL, Nagtegaal ID. The importance of the pathologist’s role in assessment of the quality of the mesorectum. Curr Colorectal Cancer Rep 2012;8:90-8.
3. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005;23:9257-64.
4. Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235:449.
5. Loughrey M, Quirke P, Shepherd N. Standards and datasets for reporting cancers: dataset for colorectal cancer. London: The Royal College of Pathologists; 2017.
6. Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 2005;242:74.
7. West NP, Finan PJ, Anderin C, Lindholm J, Holm T, et al. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 2008;26:3517-22.
8. Salerno G, Chandler I, Wotherspoon A, Thomas K, Moran B, et al. Sites of surgical waisting in the abdominoperineal specimen. Br J Surg 2008;95:1147-54.
9. Quirke P, Dixon M, Durdey P, Williams N. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986;328:996-9.
10. Mercury Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006;333:779.
11. Kapiteijn E, Putter H, Van de Velde C. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002;89:1142-9.
12. Martling AL, Holm T, Rutqvist L, Moran B, Heald R, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 2000;356:93-6.
13. Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, et al. A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002;45:857-66.
14. Morris E, Birch R, West N, Finan P, Forman D, et al. Low abdominoperineal excision rates are associated with high-workload surgeons and lower tumour height. Is further specialization needed? Colorectal Dis 2011;13:755-61.
15. Tilney HS, Heriot AG, Purkayastha S, Antoniou A, Aylin P, et al. A national perspective on the decline of abdominoperineal resection for rectal cancer. Ann Surg 2008;247:77-84.
16. Morris E, Quirke P, Thomas JD, Fairley L, Cottier B, et al. Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut 2008;57:1690-7.
17. Tilney H, Tekkis P, Heriot A. Report of the national bowel cancer audit project: assessing quality. London: Association of Coloproctology of Great Britain & Ireland; 2006.
18. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 2008;26:303-12.
19. How P, Shihab O, Tekkis P, Brown G, Quirke P, et al. A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol 2011;20:e149-55.
20. Zhang XM, Dai JL, Ma SH, Liang JW, Wang Z, et al. Intra-operative perforation: a risk factor for prognosis of low rectal cancer after abdominoperineal resection. Med Oncol 2014;31:964.
21. De Nardi P, Summo V, Vignali A, Capretti G. Standard versus extralevator abdominoperineal low rectal cancer excision outcomes: a systematic review and meta-analysis. Ann Surg Oncol 2015;22:2997-3006.
22. Holm T, Ljung A, Häggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 2007;94:232-8.
23. West N, Anderin C, Smith K, Holm T, Quirke P. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg 2010;97:588-99.
24. Stelzner S, Koehler C, Stelzer J, Sims A, Witzigmann H. Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview. Int J Colorectal Dis 2011;26:1227.
25. Quirke P, Thorpe H, Dewberry S. Prospective assessment of the quality of surgery in the MRC CLASICC trial evidence for variation in the plane of surgery in colon cancer, local recurrence and survival Birmingham, United Kingdom: National Cancer Research Institute conference; 2008.
26. Quirke P, Steele R, Monson J, Grieve R, Khanna S, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009;373:821-8.
27. Quirke P, Dixon M. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 1988;3:127-31.
28. Eriksen M, Wibe A, Syse A, Haffner J, Wiig J. Inadvertent perforation during rectal cancer resection in Norway. Br J Surg 2004;91:210-6.
29. Union for International Cancer Control. TNM Classification of Malignant Tumours. Oxford, UK: Wiley-Blackwell; 2017.
30. Bülow S, Christensen IJ, Iversen LH, Harling H; Danish Colorectal Cancer Group. Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer. Colorectal Dis 2011;13:1256-64.
31. Martijnse IS, Dudink RL, West NP, Wasowicz D, Nieuwenhuijzen GA, et al. Focus on extralevator perineal dissection in supine position for low rectal cancer has led to better quality of surgery and oncologic outcome. Ann Surg Oncol 2012;19:786-93.
32. National Institute for Health and Care Excellence. Colorectal cancer: diagnosis and management [CG131]. London: 2014.
33. Patel UB, Taylor F, Blomqvist L, George C, Evans H, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011;29:3753-60.
34. Burton S, Brown G, Daniels I, Norman A, Mason B, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer 2006;94:351.
35. Jessop J, Beagley C, Heald R. The Pelican Cancer Foundation and The English National MDT-TME Development Programme. Colorectal Dis 2006;8:1-2.
36. Taylor C, Sippitt JM, Collins G, McManus C, Richardson A, et al. A pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team members. BMC health Serv Res 2010;10:187.
37. Moran B, Holm T, Brannagan G, Chave H, Quirke P, et al. The English national low rectal cancer development programme: key messages and future perspectives. Colorectal Dis 2014;16:173-8.
38. Foster J, Gash K, Carter F, West N, Acheson A, et al. Development and evaluation of a cadaveric training curriculum for low rectal cancer surgery in the English LOREC National Development Programme. Colorectal Dis 2014:16.
39. Blong J, Chhabra A, James K, Arumagam P, Feldman M. PWE-403 Impact of the lorec programme on low rectal cancer surgery in a UK hospital. Gut 2015;64:A387-8.
40. Moran B, Dattani M. “SPECC and SPECULATION”: Is a significant polyp benign or an early colorectal cancer? How do we know and what do we do? Colorectal Dis 2016;18:745-8.
41. Heald R, Husband E, Ryall R. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg 1982;69:613-6.
42. Beets-Tan R, Beets G, Vliegen R, Kessels A, Van Boven H, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001;357:497-504.
43. Brown G, Richards CJ, Newcombe RG, Dallimore NS, Radcliffe AG, et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999;211:215-22.
44. Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma: a prospective randomized trial. Cancer 1990;66:49-55.